Trial Profile
Phase I trial of Sinovac Biotech's Avian influenza A virus vaccine-H7N9
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 12 Feb 2014
Price :
$35
*
At a glance
- Drugs Influenza A virus vaccine H7N9 (Primary)
- Indications Influenza A virus H7N9 subtype
- Focus Adverse reactions
- 12 Feb 2014 New trial record
- 29 Jan 2014 Sinovac Biotech has submitted a Clinical Trial Application(CTA) with the China Food and Drug Administration (CFDA) to commence human clinical trials for its vaccine against Avian influenza A (H7N9) virus, according to a media release.